Michel de Wilde
Director/Board Member presso VBI VACCINES INC.
Patrimonio netto: 1 005 $ in data 31/03/2024
Profilo
Michel de Wilde is currently an Independent Director at VBI Vaccines, Inc., a Director at VBI Vaccines (Delaware), Inc., and a Director at Verband Beratender Ingenieure VBI.
He was formerly a Director at Infectious Disease Research Institute from 2014 to 2019, an Independent Director at VBI Vaccines, Inc., and a Senior Vice President-Research & Development at Sanofi Pasteur, Inc. from 2001 to 2013.
He received a doctorate degree from Université Libre de Bruxelles in 1976 and an undergraduate degree from the same institution in 1971.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
VBI VACCINES, INC.
0.01% | 27/07/2023 | 1 666 ( 0.01% ) | 1 005 $ | 31/03/2024 |
Posizioni attive di Michel de Wilde
Società | Posizione | Inizio |
---|---|---|
VBI VACCINES INC. | Director/Board Member | 01/05/2016 |
Verband Beratender Ingenieure VBI
Verband Beratender Ingenieure VBI Miscellaneous Commercial ServicesCommercial Services Verband Beratender Ingenieure VBI is a consulting and engineering association based in Germany. | Director/Board Member | 01/07/2014 |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Director/Board Member | 01/07/2014 |
Precedenti posizioni note di Michel de Wilde
Società | Posizione | Fine |
---|---|---|
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Director/Board Member | 01/12/2019 |
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Chief Tech/Sci/R&D Officer | 01/06/2013 |
Sanofi Pasteur, Inc.
Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Chief Tech/Sci/R&D Officer | 01/06/2013 |
VBI VACCINES INC | Director/Board Member | - |
Formazione di Michel de Wilde
Université Libre de Bruxelles | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
VBI VACCINES INC. | Health Technology |
Aziende private | 6 |
---|---|
Sanofi Pasteur, Inc.
Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Health Technology |
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Health Technology |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Commercial Services |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Health Technology |
Verband Beratender Ingenieure VBI
Verband Beratender Ingenieure VBI Miscellaneous Commercial ServicesCommercial Services Verband Beratender Ingenieure VBI is a consulting and engineering association based in Germany. | Commercial Services |
VBI Vaccines, Inc. /Old/
VBI Vaccines, Inc. /Old/ BiotechnologyHealth Technology VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Michel de Wilde